Breaking News Instant updates and real-time market news.

BHGE

Baker Hughes

$21.22

-0.4 (-1.85%)

08:25
12/19/18
12/19
08:25
12/19/18
08:25

Baker Hughes upgraded to Outperform at Credit Suisse

As previously reported, Credit Suisse analyst James Wicklund upgraded Baker Hughes to Outperform from Neutral as he updates his sector-wide macro forecasts for a lower expected oil price. The analyst also lowered his price target on the shares to $25 from $33.

  • 10

    Feb

BHGE Baker Hughes
$21.22

-0.4 (-1.85%)

12/19/18
FBCO
12/19/18
UPGRADE
FBCO
Outperform
Baker Hughes upgraded to Outperform from Neutral at Credit Suisse
12/10/18
SUSQ
12/10/18
NO CHANGE
Target $24
SUSQ
Neutral
GE stake in Baker Hughes remains an overhang, says Susquehanna
Susquehanna analyst Charles Minervino said Baker Hughes (BHGE) management expressed optimism about its end market diversification, global oilfield footprint and robust backlog in recent meetings and noted the company has not made any changes to its outlook assumptions disclosed on the Q3 call. While he thinks Baker Hughes has done "a very admirable job" of managing the new organization since the GE (GE) merger, Minervino keeps a Neutral rating on the stock given the lingering GE 50.4% ownership overhang. After lowering his 2019 EPS estimate to $1.29 from $1.39 to account for model changes and the recent move in crude prices, Minervino lowered his price target on Baker Hughes shares to $24 from $31.
11/20/18
GDHS
11/20/18
NO CHANGE
Target $10
GDHS
Underperform
GE 'fire sale' of Baker Hughes stake a 'net negative,' says Gordon Haskett
Gordon Haskett analyst John Inch, who maintains an Underperform rating and $10 price target on General Electric (GE) shares, said the sale of Baker Hughes (BHGE) shares generates cash and in theory should be a credit "positive", but given that the sale is being done so far below book value leads him to conclude it is instead a net "negative." Even though GE should realize about $3.8B in proceeds from the sale, Inch believes the company's balance sheet could come under further stress given likely additional write-downs associated with the "fire sale" of Baker Hughes sales, he tells investors.
11/05/18
UBSW
11/05/18
NO CHANGE
Target $38
UBSW
Buy
Baker Hughes price target lowered to $38 from $45 at UBS
UBS analyst Sasha Sanwal lowered his price target on Baker Hughes to $38 from $45 following Q3 results. The analyst believes the LNG and offshore businesses are poised for inflection and puts attention on the company as a defensive play. Sanwal reiterated his Buy rating on Baker Hughes shares.

TODAY'S FREE FLY STORIES

VZ

Verizon

$61.05

0.64 (1.06%)

07:13
10/21/19
10/21
07:13
10/21/19
07:13
Hot Stocks
Verizon to deploy 5G home internet in Chicago »

Starting October 24,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 26

    Oct

  • 19

    Nov

  • 09

    Dec

PEP

PepsiCo

$136.25

-0.74 (-0.54%)

, KDP

Keurig Dr Pepper

$27.58

-0.01 (-0.04%)

07:12
10/21/19
10/21
07:12
10/21/19
07:12
Recommendations
PepsiCo, Keurig Dr Pepper analyst commentary  »

Morgan Stanley suggests…

PEP

PepsiCo

$136.25

-0.74 (-0.54%)

KDP

Keurig Dr Pepper

$27.58

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LNDC

Landec

$9.41

0.14 (1.51%)

07:11
10/21/19
10/21
07:11
10/21/19
07:11
Conference/Events
Landec management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 28

    Oct

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

LAC

Lithium Americas

$3.02

0.04 (1.34%)

07:09
10/21/19
10/21
07:09
10/21/19
07:09
Hot Stocks
Lithium Americas appoints Yuan Gao to board of directors »

Lithium Americas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$9.13

-0.17 (-1.83%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Hot Stocks
ArQule announces preclinical data showing potential for miransertib to treat VMs »

ArQule announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 30

    Oct

SON

Sonoco

$58.07

0.85 (1.49%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Upgrade
Sonoco rating change  »

Sonoco upgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$130.91

-1.46 (-1.10%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Conference/Events
Disney management to meet with Oppenheimer »

Luncheon Meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 07

    Nov

IDRA

Idera Pharmaceuticals

$2.68

-0.01 (-0.37%)

07:07
10/21/19
10/21
07:07
10/21/19
07:07
Hot Stocks
Idera Pharmaceuticals annnounces U.S. patent for tilsotolimod »

Idera Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBI

Brickell Biotech

$4.10

-0.08 (-1.91%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Conference/Events
Brickell Biotech management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

SEAS

SeaWorld

$27.88

0.23 (0.83%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
SeaWorld to open second Sesame Place theme park in San Diego in 2021 »

SeaWorld and Sesame…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARMP

Armata Pharmaceuticals

$4.10

0.05 (1.23%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
Armata Pharmaceuticals announces receipt of $1.3M R&D Tax Incentive »

Armata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGTC

Applied Genetic

$3.05

-0.06 (-1.93%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
Applied Genetic presents data from non-clinical studies evaluating AAV vectors »

Applied Genetic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$236.29

0.99 (0.42%)

07:05
10/21/19
10/21
07:05
10/21/19
07:05
Recommendations
Apple analyst commentary  »

iPhone Pro lead times…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

AXLA

Axcella

$5.10

0.14 (2.82%)

07:05
10/21/19
10/21
07:05
10/21/19
07:05
Conference/Events
Axcella management to meet with SVB Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 08

    Nov

07:05
10/21/19
10/21
07:05
10/21/19
07:05
General news
European stock markets are broadly higher »

European stock markets…

07:05
10/21/19
10/21
07:05
10/21/19
07:05
General news
FX Update: Sterling has outperformed »

FX Update: Sterling has…

AZN

AstraZeneca

$43.86

-0.25 (-0.57%)

07:04
10/21/19
10/21
07:04
10/21/19
07:04
Hot Stocks
AstraZeneca announces FDA approval of Farxiga »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 18

    Nov

  • 07

    Dec

AXSM

Axsome Therapeutics

$21.08

-1.46 (-6.48%)

07:04
10/21/19
10/21
07:04
10/21/19
07:04
Hot Stocks
Axsome Therapeutics completes patient enrollment in CONCERT Phase 2 trial »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGX

Argan

$39.36

0.82 (2.13%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Conference/Events
Argan management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ALKS

Alkermes

$18.17

0.45 (2.54%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Hot Stocks
Alkermes partners with Fred Hutchinson Cancer center to evalute ALKS 4230 »

Alkermes has entered into…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

AYTU

Aytu BioScience

$1.20

-0.04 (-3.23%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Hot Stocks
Aytu BioScience reports addition of Tuzistra XR to national PBM formulary »

Aytu BioScience announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$58.91

-1.35 (-2.24%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Hot Stocks
Teradyne to acquire AutoGuide Mobile Robots for $165M »

Teradyne and AutoGuide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

BIOL

Biolase

$0.80

-0.199 (-19.90%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Earnings
Biolase sees Q3 net loss ($5.4M)-($5.8M) »

Q3 EPS consensus (13c).…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

RESN

Resonant

$2.32

-0.12 (-4.92%)

07:01
10/21/19
10/21
07:01
10/21/19
07:01
Hot Stocks
Resonant says customers shipped more than 1.5M units in Q3 »

Resonant announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

GCI

Gannett

$10.91

-0.01 (-0.09%)

, NEWM

New Media

$8.89

0.08 (0.91%)

06:59
10/21/19
10/21
06:59
10/21/19
06:59
Periodicals
Gannett, New Media deal could be in jeopardy due to regulatory glitch, NYP says »

The proposed acquisition…

GCI

Gannett

$10.91

-0.01 (-0.09%)

NEWM

New Media

$8.89

0.08 (0.91%)

APO

Apollo Global

$39.96

-0.06 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 07

    Nov

  • 14

    Nov

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.